dailymed-drugs:218 | rdf:type | http://www4.wiwiss.fu-berli... | lld:dailymed |
dailymed-drugs:218 | rdf:type | dailymed-instance:drugs | lld:dailymed |
dailymed-drugs:218 | rdfs:label | Pristiq (Tablet, Extended Release) | lld:dailymed |
dailymed-drugs:218 | dailymed-instance:activeIng... | dailymed-ingredient:desvenl... | lld:dailymed |
dailymed-drugs:218 | dailymed-instance:boxedWarn... | WARNING: SUICIDALITY AND ANTIDEPRESSANT DRUGS: Antidepressants increased the risk compared to placebo
of suicidal thinking and behavior (suicidality) in children, adolescents,
and young adults in short-term studies of Major Depressive Disorder
(MDD) and other psychiatric disorders. Anyone considering the use
of Pristiq or any other antidepressant in a child, adolescent, or
young adult must balance this risk with the clinical need. Short-term
studies did not show an increase in the risk of suicidality with antidepressants
compared to placebo in adults beyond age 24; there was a reduction
in risk with antidepressants compared to placebo in adults aged 65
and older. Depression and certain other psychiatric disorders are
themselves associated with increases in the risk of suicide. Patients
of all ages who are started on antidepressant therapy should be monitored
appropriately and observed closely for clinical worsening, suicidality,
or unusual changes in behavior. Families and caregivers should be
advised of the need for close observation and communication with the
prescriber. Pristiq is not approved for use in pediatric patients
[ see Warnings and Precautions (5.1),
Use in Specific Populations (8.4), and Patient Counseling Information (17.1)]. | lld:dailymed |
dailymed-drugs:218 | dailymed-instance:activeMoi... | dailymed-ingredient:desvenl... | lld:dailymed |
dailymed-drugs:218 | dailymed-instance:inactiveI... | dailymed-ingredient:dextros... | lld:dailymed |
dailymed-drugs:218 | dailymed-instance:inactiveI... | dailymed-ingredient:magnesi... | lld:dailymed |
dailymed-drugs:218 | dailymed-instance:inactiveI... | dailymed-ingredient:microcr... | lld:dailymed |
dailymed-drugs:218 | dailymed-instance:inactiveI... | dailymed-ingredient:hyprome... | lld:dailymed |
dailymed-drugs:218 | dailymed-instance:inactiveI... | dailymed-ingredient:titaniu... | lld:dailymed |
dailymed-drugs:218 | dailymed-instance:inactiveI... | dailymed-ingredient:talc | lld:dailymed |
dailymed-drugs:218 | dailymed-instance:inactiveI... | dailymed-ingredient:stearic... | lld:dailymed |
dailymed-drugs:218 | dailymed-instance:inactiveI... | dailymed-ingredient:maltode... | lld:dailymed |
dailymed-drugs:218 | dailymed-instance:inactiveI... | dailymed-ingredient:sodium_... | lld:dailymed |
dailymed-drugs:218 | dailymed-instance:inactiveI... | dailymed-ingredient:iron_ox... | lld:dailymed |
dailymed-drugs:218 | dailymed-instance:genericMe... | Desvenlafaxine succinate | lld:dailymed |
dailymed-drugs:218 | dailymed-instance:fullName | Pristiq (Tablet, Extended Release) | lld:dailymed |
dailymed-drugs:218 | dailymed-instance:represent... | http://www4.wiwiss.fu-berli... | lld:dailymed |
dailymed-drugs:218 | dailymed-instance:routeOfAd... | http://www4.wiwiss.fu-berli... | lld:dailymed |
dailymed-drugs:218 | dailymed-instance:name | Pristiq | lld:dailymed |
http://www4.wiwiss.fu-berli... | dailymed-instance:producesD... | dailymed-drugs:218 | lld:dailymed |